Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33

Medulloblastoma is the most common malignant tumor that arises from the cerebellum of the central nervous system. Clinically, medulloblastomas are treated by surgery, radiation, and chemotherapy, all of which result in toxicity and morbidity. Recent reports have identified that DDX3, a member of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Tantravedi, Saritha, Vesuna, Farhad, Winnard, Paul T., Martin, Allison, Lim, Michael, Eberhart, Charles G., Berlinicke, Cynthia, Raabe, Eric, van Diest, Paul J., Raman, Venu
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2018
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171097/
https://ncbi.nlm.nih.gov/pubmed/30292066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.09.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados